Even Healthcare, a Bengaluru-based health-tech startup, has successfully closed a $50 million Series B funding round led by Khosla Ventures, marking a significant milestone in its mission to overhaul the traditional healthcare delivery model in the world’s most populous nation. The all-equity round, which also saw participation from Alpha Wave, has propelled the company’s valuation to $300 million—a threefold increase from its valuation just 18 months ago. This latest infusion of capital brings Even’s total funding to over $120 million since its inception in 2021, signaling strong investor confidence in a model that prioritizes patient outcomes over the volume of medical procedures.
The startup’s primary objective is to address a systemic flaw in the Indian healthcare landscape: the "fee-for-service" model. In most Indian private hospitals, revenue is directly tied to the number of tests conducted, the complexity of surgeries performed, and the length of patient stays. This often creates a misalignment of incentives, where hospitals may be encouraged to recommend unnecessary diagnostic tests or prolonged hospitalizations to maximize billing. Even Healthcare aims to disrupt this cycle by implementing a "value-based care" framework, where the focus is shifted toward preventative medicine and efficient, necessary treatments.
A Strategic Shift to Integrated Care Delivery
Initially launched as a healthcare membership service that partnered with existing hospitals to provide care for its members, Even Healthcare underwent a significant strategic pivot. According to Mayank Banerjee, who co-founded the company alongside Matilde Giglio and Alessandro Ialongo, the decision to build and operate their own hospitals was born out of necessity. After analyzing patient data from third-party providers, the founders discovered instances where members were being recommended for surgeries or diagnostic panels that the startup’s internal medical board deemed medically unnecessary.
To gain full control over the clinical pathway and the economic levers of care, Even began establishing its own physical infrastructure. The company currently operates two hospitals in Bengaluru. Remarkably, both facilities achieved operational profitability (excluding depreciation) within their first year of operation. The Series B funding is earmarked to accelerate this physical expansion, with plans to open five additional hospitals across Bengaluru within the next six months.
By leasing hospital buildings on 20-year agreements and investing in the internal fit-outs and high-end medical equipment, Even follows an "asset-light" approach to infrastructure while maintaining total control over the medical practice. This integrated model—combining financing (through insurance partnerships), technology (for patient tracking), and delivery (through owned hospitals)—is designed to create a closed-loop system where efficiency is rewarded.
Rewriting the Script for Physician Compensation
Central to Even’s disruption of the traditional model is how it compensates its medical staff. In many private Indian healthcare settings, doctors may receive commissions or "referral fees" for prescribing certain tests or referring patients to specialists within the same network. Even has eliminated this practice entirely.
The company employs approximately 300 full-time doctors who are paid fixed, competitive salaries. Their compensation is decoupled from the revenue they generate for the hospital. Instead, physicians are eligible for bonuses based on patient-reported clinical outcomes and satisfaction scores. This ensures that the doctor’s primary motivation is the recovery and long-term health of the patient rather than the hospital’s bottom line.
This philosophy extends to the management and marketing teams. Marketing efforts are focused on patient acquisition and volume of care rather than the average revenue per occupied bed (ARPOB), a common metric used in the corporate hospital sector. Furthermore, every employee at Even, from surgeons to administrative staff, is granted equity in the company. The goal is to foster a culture of long-term ownership where employees benefit from the company’s overall success and reputation for quality, rather than short-term billing spikes.
Data-Driven Outcomes and Economic Impact
Even Healthcare relies heavily on standardized medical scoring systems to prove the efficacy of its "outcome-based" approach. For example, for orthopedic procedures such as knee replacements, the startup utilizes the Oxford Knee Score to measure post-operative pain levels and mobility improvements. By publishing these results on its website and comparing them with industry benchmarks, the company aims to bring a level of transparency to Indian healthcare that has historically been lacking.
The clinical data released by the startup suggests significant improvements over industry averages:
- Readmission Rates: Even reports an unplanned readmission rate of less than 1%, significantly lower than the industry benchmark of 8% to 15%.
- Hospital Stay Duration: Patients treated within the Even ecosystem reportedly spend 40% less time in the hospital compared to those in traditional settings for similar conditions.
- Insurer Savings: The startup claims its preventative and efficiency-focused approach has saved insurance partners more than ₹500 million (approximately $5.27 million) by avoiding unnecessary interventions.
While the startup generates the majority of its revenue from direct patient payments for treatment, it is also pioneering new revenue streams through its relationships with insurers. Even is currently working on a model where it would be compensated for "hospitalizations prevented"—essentially a "keep-well" premium that aligns the financial interests of the hospital with the health of the patient.
Navigating Financial Realities and Market Challenges
Despite its rapid valuation growth and operational successes in individual facilities, Even Healthcare remains in a period of heavy investment and net losses. Regulatory filings for fiscal year 2025 reveal a net loss of ₹902 million (approximately $9.50 million), a 25% increase from the previous year. This loss occurred on revenue of ₹272 million (approximately $2.86 million).
The path to profitability has also required internal restructuring. In August 2024, the company laid off approximately 350 employees, a move Banerjee described as a difficult but necessary step to streamline operations as the company moved deeper into hospital management. To mitigate the impact on affected staff, the company provided severance packages, extended health insurance, and accelerated equity vesting.
Currently, Even employs a total of 650 people and serves a membership base of roughly 250,000 individuals. Since its launch three years ago, the platform has facilitated more than 750,000 patient interactions, ranging from routine primary care consultations to complex surgical procedures.
Investor Perspective and the Future of Value-Based Care
The involvement of Khosla Ventures, a firm known for its early bets on transformative technologies and "impossible" ideas, underscores the potential global relevance of Even’s model. Vinod Khosla, the firm’s founder, has long advocated for the use of technology and restructured incentives to solve the "healthcare crisis" of rising costs and declining access.
"Even’s approach goes beyond fixing individual parts of a fragmented healthcare system by bringing financing, technology, and care delivery together," Khosla said in a statement. He emphasized that the goal is to create a model that can be replicated not just across India, but in other markets struggling with healthcare inflation and inefficient delivery systems.
Jai Sajnani, a partner at Khosla Ventures, noted that the early operational profitability of Even’s first two hospitals was a deciding factor in leading the Series B round. The ability to prove that a value-based model can be financially viable in a highly competitive market like Bengaluru provides a blueprint for further expansion.
Conclusion and Industry Implications
The rise of Even Healthcare comes at a time when the Indian government is pushing for greater digital integration in healthcare through the Ayushman Bharat Digital Mission (ABDM). As more patients enter the formal healthcare system and insurance penetration increases, the demand for transparent, high-quality, and cost-effective care is expected to surge.
Even’s model challenges the established giants of the Indian private healthcare sector by suggesting that the "corporate hospital" model of the 1990s and 2000s may no longer be the most efficient way to serve the modern Indian middle class. By focusing on Bengaluru—often called the "Silicon Valley of India"—Even is targeting a demographic that is tech-savvy, values transparency, and is increasingly skeptical of traditional medical billing practices.
While the startup faces significant hurdles, including the high capital expenditure required for hospital expansion and the ongoing challenge of reaching company-wide profitability, its $50 million boost provides the runway needed to test its hypothesis at scale. If Even can maintain its low readmission rates and high patient satisfaction scores while expanding to seven hospitals, it may well force a broader reckoning within the Indian medical industry regarding how success is measured and how doctors are rewarded. For now, the startup remains focused on growth, betting that in the long run, better health outcomes will lead to a better bottom line.
